NFKB1 and acute myeloid leukemia: Cytarabine (Ara-C) treatment prompted AML cells to express and secret TNF-α, which subsequently facilitated the expansion of MDSCs and enhanced their function and survival through activating IL-6/STAT3 and NFκB pathways (143).